Antihypertensive effects of bioactive tripeptides - A random effects meta-analysis

Annals of Medicine

Volumn 45, Issue 1, 2013, Pages 51-56

  Turpeinen, Anu M ^a   Järvenpää, Salme ^b   Kautiainen, Hannu ^d,e   Korpela, Riitta ^c   Vapaatalo, Heikki ^c  

^a VALIO LTD   (Finland)

^b Finland MedCare Ltd   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Central Finland Central Hospital   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antihypertensive effect; Bioactive peptides; Blood pressure; IPP; Key words:; Meta analysis; VPP

Indexed keywords

ISOLEUCINE; PLACEBO; PROLINE; TRIPEPTIDE; VALINE;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DIASTOLIC BLOOD PRESSURE; FERMENTED PRODUCT; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MEDLINE; MILK; PREHYPERTENSION; PRIORITY JOURNAL; PUBLICATION; REVIEW; SAMPLE SIZE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CONFIDENCE INTERVALS; DIETARY SUPPLEMENTS; HUMANS; HYPERTENSION; MILK PROTEINS; OLIGOPEPTIDES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84870646062     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2012.663926     Document Type: Review

References (37)

1. Miller ED Jr, Samuel AI, Haber E, Barger 1. AC. Inhibition of angiotensin conversion in experimental renovascular hypertension. Science. 1972;177:1106-9.
2. Jäkälä P, Vapaatalo H. Antihypertensive peptides from milk protein. Pharmaceuticals. 2010;3:251- 72.
3. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. Purifi cation and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci. 1995;78:777-83.
4. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta aft er oral administration of sour milk containing these peptides in spontaneously hypertensive rats. J Nutr. 1996;126:3063-8. (Pubitemid 27023881)
5. Luhtala S, Vaajanen A, Oksala O, Valjakka J, Vapaatalo H. Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine tissues. J Ocul Pharmacol Th er. 2009;25:23-8.
6. Leo FD, Panarese S, Gallerani R, Ceci LR. Angiotensin converting enzyme (ACE) inhibitory peptides: Production and implementation of functional food. Curr Pharmaceut Des. 2009;15:3622-43.
7. Ehlers PI, Kivim äk i AS, Turpeinen AM, Korpela R, Vapaatalo H. High blood pressure lowering and vasoprotective eff ects of milk products in experimental hypertension. Br J Nutr. 2011;106:1353-63.
8. Xu J-Y, Qin L-Q, Wang P-Y, Li W, Chang C. Eff ects of milk tripeptides on blood pressure: A meta-analysis of randomized controlled trials. Nutrition. 2008;24:933-40.
9. Cicero AFG, Gerocarni B, Laghi L, Borghi C. Blood pressure lowering eff ect of lactotripeptides assumed as functional foods: A meta-analysis of current available clinical trials. J Hum Hypertens. 2010;25:1-12.
10. Pripp AH. Eff ect of peptides derived from food proteins on blood pressure: A meta-analysis of randomized controlled trials. Food Nutr Res. 2008;52. doi: 10.3402/fnr.v25i0.1641.
11. Engberink MF, Schouten EG, Kok FJ, van Mierlo LAJ, Brouwer IA, Geleijnse JM. Lactotripeptides show no eff ect in human blood pressure. Hypertension. 2008;51:399- 405.
12. van Mierlo LAJ, Koning MMG, van der Zander K, Draijer R. Lactotripeptides do not lower blood pressure in untreated whites: Results from 2 controlled multicenter crossover studies. Am J Clin Nutr. 2009;89:617-23.
13. van der Zander K, Bots ML, Bak AAA, Koning MMG, de Leeuw PW. Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. Am J Clin Nutr. 2008;88:1697-702.
14. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. A placebo-controlled study of the eff ect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr. 1996;64:767-71. (Pubitemid 26398281)
15. Kajimoto O, Aihara K, Hirata H, Takahashi R, Nakamura Y. Hypotensive eff ects of tablets containing " lactotripeptides (VPP, IPP) " . J Nutr Food. 2001;4:51-61.
16. Kajimoto O, Nakamura Y, Yada H, Moriguchi S, Hirata H, Takahashi T. Hypotensive eff ects of sour milk in subjects with mild or moderate hypertension. J Jpn Soc Nutr Food Sci. 2001;54:347-54.
17. Kajimoto O, Kurosaki T, Mizutani J, Nagisa I, Kaneko K, Aihara K, et a l. Antihypertensive eff ects of liquid yoghurts containing " lactotripeptides (VPP, IPP) " in mild hypertensive subjects. J Nutr Food. 2002;5: 55-66.
18. Hirata H, Nakamura Y, Yada H, Moriguchi S, Kajimoto O, Takahashi T. Clinical eff ects of new sour milk drink on mild or moderate hypertensive subjects. J New Rem Clin. 2002;51:61-9.
19. Seppo L, Kerojoki O, Suomalainen T, 19. Korpela R. Th e eff ect of a Lactobacillus helveticus LBK-16H fermented milk on hypertension-a pilot study on humans. Milchwissenschaft . 2002;57:124-7. (Pubitemid 34881652)
20. Seppo L, Jauhiainen T, Poussa T, Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering eff ect in hypertensive subjects. Am J Clin Nutr. 2003;77:326-30. (Pubitemid 36133373)
21. Mizushima S, Oshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Y, et al. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens. 2004;17: 701-6. (Pubitemid 39091551)
22. Nakamura Y, Kajimoto O, Kaneko K, Aihara K, Mizutani J, Ikeda N, et al. Eff ects of the liquid yogurts containing " lactotripeptide (VPP, IPP) " on high normal blood pressure. J Nutr Food. 2004;7:123-37.
23. Tuomilehto J, Lindströ m J, Hyyrynen J, Korpela R, Karhunen M-L, Mikkola L, et al. Eff ect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing peptides on blood pressure in subjects with mild hypertension. J Hum Hypertens. 2004;18:795-802. (Pubitemid 39530092)
24. Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M, et al. Antihypertensive eff ect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr. 2005;94:84-91. (Pubitemid 41357814)
25. Sano J, Ohki K, Higuchi T, Aihara K, Mizuno S, Kajimoto O, et al. Eff ect of casein hydrolysate, prepared with protease derived from Aspergillus oruzae on subjects with high-normal blood pressure or mild hypertension. J Med Food. 2005;8:423-30. (Pubitemid 43121892)
26. van der Zander K, Jäkel M, Bianco V, Koning MMG. Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects. J Hum Hypertens. 2008;22: 804-6.
27. de Leeuw PW, van der Zander K, Kroon AA, Rennenberg RMW, Koning MMG. Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. Blood Press. 2009;18:44-50.
28. Turpeinen AM, Kumpu M, Rönnback M, Seppo L, Kautiainen H, Jauhiainen T, et al. Antihypertensive and cholesterol-lowering eff ects of a spread containing bioactive peptides Ile-Pro-Pro and Val-Pro-Pro and plant sterols. J Funct Foods. 2009;1:260-5.
29. Jauhiainen T, Rönnback M, Vapaatalo H, Wuolle K, Kautiainen H, Groop P-H, et al. Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. Eur J Clin Nutr. 2010;64:424-31.
30. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and coronary heart disease. Br Med Bull. 1994:365:272-98. (Pubitemid 24165020)
31. Krousel-Wood MA, Muntner P, He J, Whelton PK. Primary prevention of essential hypertension. Med Clin North Am. 2004:88: 223-38. (Pubitemid 38160947)
32. Jauhiainen T, Wuolle K, Vapaatalo H, Kerojoki O, Nurmela K, Lowrie C, et al. Oral absorption, tissue distribution and excretion of radiolabelled analog of milk-derived antihypertensive peptide, Ile-Pro-Pro in rats. Int Dairy J. 2007;17:1216-23. (Pubitemid 47095279)
33. Jauhiainen T, Rönnback M, Vapaatalo H, Wuolle K, Kautiainen H, Korpela R. Lactobacillus helveticus fermented milk reduces arterial stiff-ness in hypertensive subjects. Int Dairy J. 2007;17:1209-11. (Pubitemid 47095280)
34. van Mierlo LAJ, Arends LR, Streppel MT, Zeegers MPA, Kok FJ, Grobbee DE, et al. Blood pressure response to calcium supplementation: A meta-analysis of randomized controlled trials. J Hum Hypertens. 2006;20:571-80. (Pubitemid 44088959)
35. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, et a l. Eff ect of oral potassium on blood pressure. Meta-analysis of randomized controled clinical trials. JAMA. 1997;277:1624-32. (Pubitemid 27231195)
36. Dickinson HO, Nicolson D, Campbell F, Beyer FR, Mason J. Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006;3:CD004641.
37. Cicero AFG, Rosticci M, Veronesi M, Bacchelli S, Strocchi E, Melegari C, et al. Hemodynamic eff ects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with highnormal blood pressure: A randomized, double-blind, crossover clinical trial. J Med Food. 2010;13:1363-8.